Cytoplasmic islet cell antibodies remain valuable in defining risk of progression to type 1 diabetes in subjects with other islet autoantibodies.

Pietropaolo, Massimo

Cytoplasmic islet cell antibodies remain valuable in defining risk of progression to type 1 diabetes in subjects with other islet autoantibodies. [electronic resource] - Pediatric diabetes Dec 2005 - 184-92 p. digital

Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't

1399-543X

10.1111/j.1399-543X.2005.00127.x doi


Adolescent
Adult
Animals
Autoantibodies--blood
Biomarkers--blood
Child
Child, Preschool
Diabetes Mellitus, Type 1--epidemiology
Disease Progression
Family
Female
Glutamate Decarboxylase--immunology
Humans
Infant
Islets of Langerhans--immunology
Isoenzymes--immunology
Longitudinal Studies
Male
Prevalence
Rats
Risk Assessment